Literature DB >> 6350584

Systemic sclerosis--a microvascular disorder?

M I Jayson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6350584      PMCID： PMC1439277          DOI： 10.1177/014107688307600804

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  67 in total

1.  Dermal fibrosis following subcutaneous injections of serotonin creatinine sulphate.

Authors:  R A MACDONALD; S L ROBBINS; G K MALLORY
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

2.  Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report.

Authors:  N L Browse; P E Jarrett; M Morland; K Burnand
Journal:  Br Med J       Date:  1977-08-13

3.  Comparison of the microangiopathy of systemic lupus erythematosus, dermatomyositis, scleroderma, and diabetes mellitus.

Authors:  W L Norton
Journal:  Lab Invest       Date:  1970-04       Impact factor: 5.662

4.  Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran.

Authors:  W J Cunliffe; I S Menon
Journal:  Br J Dermatol       Date:  1969-03       Impact factor: 9.302

5.  Abnormal blood viscosity in Raynaud's phenomenon.

Authors:  K B Goyle; J A Dormandy
Journal:  Lancet       Date:  1976-06-19       Impact factor: 79.321

6.  The skin microcirculation and the pathogenesis of ischaemic necrosis and gangrene.

Authors:  B Fagrell
Journal:  Scand J Clin Lab Invest       Date:  1977-10       Impact factor: 1.713

7.  5-Hydroxytryptamine and tryptamine pathways in scleroderma.

Authors:  A Stachow; S Jablonska; A Skiendzielewska
Journal:  Br J Dermatol       Date:  1977-08       Impact factor: 9.302

8.  Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis.

Authors:  R E Gay; R B Buckingham; R K Prince; S Gay; G P Rodnan; E J Miller
Journal:  Arthritis Rheum       Date:  1980-02

9.  Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis.

Authors:  D E Furst; J A Davis; P J Clements; S K Chopra; A N Theofilopoulos; D Chia
Journal:  Arthritis Rheum       Date:  1981-11

10.  Immune complexes in progressive systemic sclerosis (scleroderma).

Authors:  J R Seibold; T A Medsger; A Winkelstein; R H Kelly; G P Rodnan
Journal:  Arthritis Rheum       Date:  1982-10
View more
  9 in total

1.  Increased capillary permeability in systemic sclerosis: help or hindrance?

Authors:  W Grassi; P Core; C Cervini
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

2.  Raynaud's disease.

Authors:  E C Burns; D B Dunger; M J Dillon
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

3.  Endothelial cytotoxic activity (ECA) in sera of patients with livedo racemosa generalisata Ehrmann.

Authors:  F Drenk; D Lubach; C Schwabe; H Deicher
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 4.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

5.  Limited joint mobility in diabetes mellitus.

Authors:  R R Campbell; S J Hawkins; P J Maddison; J P Reckless
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

6.  Platelet serotonin in systemic sclerosis.

Authors:  P S Klimiuk; A Grennan; C Weinkove; M I Jayson
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

7.  Failure of sera from patients with scleroderma to exhibit cytotoxicity towards human umbilical vein endothelial cells.

Authors:  G D Summers; J B Weiss; M I Jayson
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

8.  Systemic sclerosis in association with multiple primary pulmonary malignancy--a marker of internal malignancy?

Authors:  M J Goodfield; L G Millard
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

9.  Studies on endothelial cell cytotoxic activity in sera of patients with progressive systemic sclerosis, Raynaud syndrome, rheumatoid arthritis, and systemic lupus erythematosus.

Authors:  F Drenk; H Mensing; A Serbin; H Deicher
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.